Valuation: Progyny, Inc.

Capitalization 2.3B 1.96B 1.83B 1.72B 3.17B 209B 3.47B 21.39B 8.3B 98.31B 8.64B 8.46B 359B P/E ratio 2025 *
40.6x
P/E ratio 2026 * 27.9x
Enterprise value 2.17B 1.85B 1.73B 1.62B 2.99B 196B 3.27B 20.15B 7.82B 92.61B 8.14B 7.97B 338B EV / Sales 2025 *
1.7x
EV / Sales 2026 * 1.43x
Free-Float
76.13%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+2.69%
1 week+11.20%
Current month+1.29%
1 month+9.38%
3 months+18.66%
6 months+27.01%
Current year+54.84%
More quotes
1 week 23.78
Extreme 23.78
26.79
1 month 23.75
Extreme 23.75
27.51
Current year 17.01
Extreme 17.0076
27.51
1 year 13.86
Extreme 13.86
27.51
3 years 13.39
Extreme 13.39
44.95
5 years 13.39
Extreme 13.39
68.32
10 years 13.29
Extreme 13.29
68.32
More quotes
Manager TitleAgeSince
Chief Executive Officer 58 31/12/2021
President 48 31/12/2021
Director of Finance/CFO 59 14/09/2020
Director TitleAgeSince
Chairman 65 31/12/2021
Director/Board Member 50 15/12/2016
Director/Board Member 58 31/12/2021
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+2.69%+11.20%+82.82%-15.93% 2.3B
+1.52%+3.30%-34.32%-36.49% 310B
-0.32%+8.56%-5.86%-30.86% 79.8B
+0.90%+3.49%-2.54%-16.82% 73.38B
+0.74%+4.11%-2.07%-48.68% 32.29B
+0.96%+6.55%-31.25%-50.91% 20.08B
+0.96%+10.96%-44.39%-51.68% 8.66B
-0.26%-0.97%+69.08%+59.87% 3.87B
-1.82%+4.65%-13.18%+143.24% 1.4B
-2.25%-0.17%-24.41% - 385M
Average +0.31%+5.17%-0.61%-5.36% 53.18B
Weighted average by Cap. +1.06%+4.42%-22.43%-33.20%
See all sector performances

Financials

2025 *2026 *
Net sales 1.28B 1.09B 1.02B 956M 1.76B 116B 1.92B 11.85B 4.6B 54.49B 4.79B 4.69B 199B 1.4B 1.19B 1.11B 1.05B 1.93B 127B 2.1B 12.98B 5.04B 59.67B 5.24B 5.13B 218B
Net income 58.84M 50.12M 46.82M 44.05M 81.1M 5.33B 88.6M 547M 212M 2.51B 221M 216M 9.17B 84.61M 72.08M 67.33M 63.35M 117M 7.66B 127M 786M 305M 3.61B 317M 311M 13.18B
Net Debt -134M -114M -106M -99.98M -184M -12.09B -201M -1.24B -481M -5.7B -501M -490M -20.8B -304M -259M -242M -227M -419M -27.51B -457M -2.82B -1.09B -12.97B -1.14B -1.12B -47.3B
More financial data * Estimated data
Logo Progyny, Inc.
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Employees
678
More about the company
Date Price Change Volume
12/12/25 26.71 $ +2.69% 1,590,139
11/12/25 26.01 $ +3.34% 1,214,189
10/12/25 25.17 $ +1.82% 1,372,354
09/12/25 24.72 $ +0.08% 999,252
08/12/25 24.70 $ +2.83% 1,255,514

Delayed Quote Nasdaq, December 12, 2025 at 09:00 pm

More quotes
Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
26.71USD
Average target price
29.40USD
Spread / Average Target
+10.07%
Consensus

Quarterly revenue - Rate of surprise